UBS AM’s Magellan Health Services, Inc. MGLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-21,011
| Closed | -$2M | – | 2851 |
|
|
2021
Q4 | $2M | Sell |
21,011
-2,659
| -11% | -$252K | ﹤0.01% | 1872 |
|
|
2021
Q3 | $2.24M | Sell |
23,670
-3,196
| -12% | -$302K | ﹤0.01% | 1784 |
|
|
2021
Q2 | $2.53M | Buy |
26,866
+1,066
| +4% | +$100K | ﹤0.01% | 1743 |
|
|
2021
Q1 | $2.41M | Buy |
25,800
+3,219
| +14% | +$302K | ﹤0.01% | 1682 |
|
|
2020
Q4 | $1.87M | Buy |
22,581
+3,097
| +16% | +$245K | ﹤0.01% | 1714 |
|
|
2020
Q3 | $1.48M | Hold |
19,484
| – | – | ﹤0.01% | 1677 |
|
|
2020
Q2 | $1.42M | Sell |
19,484
-5,389
| -22% | -$345K | ﹤0.01% | 1654 |
|
|
2020
Q1 | $1.2M | Sell |
24,873
-2,701
| -10% | -$174K | ﹤0.01% | 1625 |
|
|
2019
Q4 | $2.16M | Buy |
27,574
+1,878
| +7% | +$132K | ﹤0.01% | 1573 |
|
|
2019
Q3 | $1.6M | Sell |
25,696
-1,911
| -7% | -$127K | ﹤0.01% | 1719 |
|
|
2019
Q2 | $2.05M | Buy |
27,607
+2,218
| +9% | +$149K | ﹤0.01% | 1577 |
|
|
2019
Q1 | $1.67M | Buy |
25,389
+1,711
| +7% | +$110K | ﹤0.01% | 1611 |
|
|
2018
Q4 | $1.35M | Buy |
23,678
+1,971
| +9% | +$122K | ﹤0.01% | 1607 |
|
|
2018
Q3 | $1.56M | Buy |
21,707
+757
| +4% | +$60.9K | ﹤0.01% | 1606 |
|
|
2018
Q2 | $2.01M | Sell |
20,950
-3,016
| -13% | -$289K | ﹤0.01% | 1509 |
|
|
2018
Q1 | $2.57M | Buy |
23,966
+3,350
| +16% | +$336K | ﹤0.01% | 1366 |
|
|
2017
Q4 | $1.99M | Buy |
20,616
+1,192
| +6% | +$105K | ﹤0.01% | 1439 |
|
|
2017
Q3 | $1.68M | Buy |
19,424
+913
| +5% | +$72K | ﹤0.01% | 1472 |
|
|
2017
Q2 | $1.35M | Sell |
18,511
-656
| -3% | -$46.1K | ﹤0.01% | 1530 |
|
|
2017
Q1 | $1.32M | Buy |
19,167
+1,802
| +10% | +$132K | ﹤0.01% | 1521 |
|
|
2016
Q4 | $1.31M | Sell |
17,365
-7,952
| -31% | -$509K | ﹤0.01% | 1459 |
|
|
2016
Q3 | $1.36M | Hold |
25,317
| – | – | ﹤0.01% | 1539 |
|
|
2016
Q2 | $1.67M | Hold |
25,317
| – | – | ﹤0.01% | 1425 |
|
|
2016
Q1 | $1.72M | Buy |
25,317
+1,786
| +8% | +$107K | ﹤0.01% | 1427 |
|
|
2015
Q4 | $1.45M | Buy |
23,531
+254
| +1% | +$13.6K | ﹤0.01% | 1594 |
|
|
2015
Q3 | $1.29M | Buy |
23,277
+9,178
| +65% | +$555K | ﹤0.01% | 1618 |
|
|
2015
Q2 | $988K | Buy |
14,099
+1,300
| +10% | +$88.4K | ﹤0.01% | 1685 |
|
|
2015
Q1 | $906K | Buy |
12,799
+500
| +4% | +$31.5K | ﹤0.01% | 1674 |
|
|
2014
Q4 | $738K | Buy |
12,299
+600
| +5% | +$35.4K | ﹤0.01% | 1731 |
|
|
2014
Q3 | $640K | Hold |
11,699
| – | – | ﹤0.01% | 1743 |
|
|
2014
Q2 | $728K | Hold |
11,699
| – | – | ﹤0.01% | 1705 |
|
|
2014
Q1 | $694K | Buy |
11,699
+2,700
| +30% | +$161K | ﹤0.01% | 1698 |
|
|
2013
Q4 | $539K | Buy |
8,999
+200
| +2% | +$11.9K | ﹤0.01% | 1772 |
|
|
2013
Q3 | $528K | Hold |
8,799
| – | – | ﹤0.01% | 1759 |
|
|
2013
Q2 | $493K | Buy |
+8,799
| New | +$461K | ﹤0.01% | 1715 |
|
UBS AM's MGLN Position: Q1 2022 in Review
UBS AM sold out of Magellan Health Services, Inc. (MGLN) in Q1 2022, closing a stake of 21,011 shares — an estimated $2M sold.
UBS AM first reported a position in MGLN in Q2 2013 and held it in 35 quarters. The position peaked at $2.57M in Q1 2018. 0 funds tracked by Wall St. Rank hold MGLN as of Q1 2022.
- UBS AM reported no remaining Magellan Health Services, Inc. position as of Q1 2022 after selling out during the quarter.
- UBS AM sold 21,011 Magellan Health Services, Inc. shares in Q1 2022, an estimated $2M.
- UBS AM first reported a position in Magellan Health Services, Inc. in Q2 2013 and held it in 35 quarters.
- UBS AM's Magellan Health Services, Inc. position peaked at $2.57M in Q1 2018.
- 0 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q1 2022.
Based on UBS AM's 13F filing for Q1 2022, filed 16 May 2022.